(Q58204655)
Statements
Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy (English)
Naoshi Nishina
Jun Kikuchi
Misato Hashizume
Keiko Yoshimoto
1 reference
1 reference
1 reference